Inventor
STEVEN JOHN DURRANT
Inventor
GB
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes28%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations28%
C07DHeterocyclic compounds28%
C07BGeneral methods of organic chemistry17%
PatentTitleYear
12,258,333N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channels202512,247,021Substituted tetrahydrofurans as modulators of sodium channels202511,919,887Substituted tetrahydrofurans as modulators of sodium channels202411,834,441Substituted tetrahydrofurans as modulators of sodium channels202311,827,627N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channels2023Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2023–2025Patents assigned to VERTEX PHARMA (5)· patent assignee history
2023–2025Based in GB· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| VERTEX PHARMA | 5 | 2023–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| GB | 5 | 2023–2025 |